F/M Emerald Life Sciences Innovation ETF
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
A fund that holds many companies, so profit, growth, price and debt are not measured for it as for one company.
AI analysis
An AI analyst reads F/M Emerald Life Sciences Innovation ETF's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Profitability
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Growth
- –
- –
- –
- –
- –
Financial health
- –
- –
- –
- –
- –
- –
- –
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
Not enough data
Questions about F/M Emerald Life Sciences Innovation ETF
Is F/M Emerald Life Sciences Innovation ETF a good stock to buy?
A fund that holds many companies, so profit, growth, price and debt are not measured for it as for one company. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the F/M Emerald Life Sciences Innovation ETF AI analysis
What does F/M Emerald Life Sciences Innovation ETF do?
LFSC seeks to invest in innovative life sciences companies that are expected to create value and long-term growth. The actively managed fund relies on a specialized and experienced team to research complex life sciences companies. It is in Asset Management.
How has F/M Emerald Life Sciences Innovation ETF stock done over the past year?
Up 33.9% over the past twelve months, to $46.38. It traded between $32.96 and $48.44 and is 4.2% below its high.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.